top of page
Search



In societies that champion health and well-being, what drives so many young lives towards a relentless pursuit of thinness, even to the brink of death? Anorexia nervosa (AN) is a severe psychiatric disorder associated with “aberrant patterns of feeding behavior and weight regulation, and deviant attitudes and perceptions toward body weight and shape”.1 In industrialized countries, eating disorders are the third most common chronic disease in female adolescents. In Western countries, the rate of AN is 0.3%.2 AN sees a high prevalence among adolescent females, yet it is multifaceted in its causation, with complex intersections of biology, psychology, and socio-cultural dynamics. Notably, this disorder has the highest mortality rate of any psychiatric condition: approximately 5% of individuals diagnosed with anorexia die within the first four years of diagnosis. Morever, AN is associated with various causes of death: suicide, pulmonary disease, diabetes, liver and other digestive disease, to shock and organ failure.3 While studies indicate that genetic factors account for approximately 40-50% of the risk for developing AN,  social components still play a key role by exposing individuals to distinct environments that can lead them to developing this devastating eating disorder.4 


Although twin studies show that genetics contribute by establishing personal traits that may increase vulnerability to AN, the primary factor remains the social environment individuals are immersed in. Historically, socio-cultural factors—especially those tied to body image and ideals of thinness—have strongly influenced the development and persistence of anorexia nervosa, forming a complex situation that demands more than clinical treatment alone. Discussions on the socio-cultural origins of AN date back to 19785, but in the 50 years since few actionable solutions have been implemented to curb its prevalence.  A cultural shift in societal standards of beauty and success is vital to disrupt the cycle that continues to trap at-risk individuals.


The societal conditioning towards thinness is alarmingly powerful. Although there is a "window of opportunity" for successful treatment during the first few years of the disorder, most young people seek help well after the eating disorder has taken root for early intervention to be effective, in part due to socio-cultural forces..6 The Tripartite Model of body dissatisfaction indicates that the sociocultural emphasis on thinness is reinforced by media, parents, and peers.4 Mass media campaigns propagate an “ideal of beauty” that endorses thinness for women, equating slenderness with success and appeal and influencing individuals, often beginning at a young age, to internalize these ideals. As Uchôa et al. reveal, a significant 45.3% of adolescents report being moderately influenced by the media. Unsurprisingly, girls are more affected, with 25.7% experiencing pronounced media influence compared to 19.6% of boys.2 These media-driven ideals exacerbate body dissatisfaction and pose an increased risk for eating disorders during a vulnerable developmental period.


The cultural contagion of disordered eating behaviors is also seen through peer dynamics. During adolescence, female friendship circles can cultivate an unhealthy focus on dieting and weight loss. Peer discussion and the ensuing social validation for losing weight often leads to a group-sanctioned pursuit of thinness, which solidifies the unhealthy idea that thinness equals beauty, within individuals. In such environments, anorexia nervosa can soon develop as adolescents strive to belong or stand out within these social hierarchies. The disorder, for some, can even become a source of identity, offering a sense of distinction and accomplishment where many peers might falter in their dieting efforts. By succeeding where others fail (at dieting, self-discipline and thinness), “the progression towards an eating disorder offers the appeal of a new adolescent identity and social distinction in the group”.6 The sense of success is further strengthened if one has genetic predisposition of having the following traits: perfectionism, the desire to correspond to a certain ideal image of oneself, instability of Ego, unstable identity violations, and reduced ability to form a picture of the future and themselves in the future.7 Personal vulnerabilities, amplified by genetic predispositions, can heighten susceptibility to the environmental triggers discissed.4


Further, these environmental triggers of anorexia nervosa are not confined to Western societies or Caucasian populations. In fact, binge eating and purging behavior are reported among Black women at least as frequently as among White women, yet AN is rarely found among Black women.8 However, differences in the prevalence or rates of occurrence of eating disorders among individuals or social groups do not mean that they are not at risk.9 Willemsen and Hoek present a case of a Black woman from Curaçao who developed AN after moving to the Netherlands. Initially, she conformed to Caribbean ideals that celebrated fuller figures, but upon exposure to Western beauty norms that idolize thinness, she changed her perception of self-worth. Mainly through television, she noticed that in the Netherlands being thin is considered attractive and that many Dutch women diet. As a result, she decided to pursue dieting and later was admitted with the AN diagnosis. This case illustrates that the patient’s ethnic background did not protect her from developing AN. It highlights the contribution of sociocultural influences, in the form of local norms regarding body size and shape, towards the development of AN. There is danger in taking too seriously the idea that some groups, particularly African-American women, are “protected” from eating problems. Assigning “immunity” to a specific group could result in the misdiagnosis and under-representation among people of different gender, racial, ethnic, sexuality and class backgrounds with eating disorders.9


Although some individuals with anorexia find a sense of community within their disorder, the stigma and isolation surrounding anorexia present substantial barriers to recovery.6 The friendships that persist at earlier stages of the disorder are frequently lost rapidly as the condition progresses, leaving the person socially isolated. Once anorexia becomes entrenched, patients often find themselves alienated from peers and friends. “Unlike other illness categories, anorexia nervosa was transformed from a clinical entity into a friend: it became Ana, a comforter – especially during the early ‘honeymoon phase’ of the disorder,” Allison et. al say.  For some, anorexia nervosa forms a sense of distorted community, where “shared experiences in inpatient or day patient settings create a 'team activity' atmosphere with its covert rules”.6 The false of community that AN patients might find themselves engulfed in, delays seeking treatment or even makes treatment impossible, as the condition often becomes self-reinforcing, embedded within a sense of belonging and understanding that the disorder falsely provides.


In addition to media and peer influences, economic and political factors are also associated with control over women's bodies. The perpetuation of the thin ideal is as much an economic construct as a cultural one, perpetuated by industries that profit from women's insecurities about their bodies. These industries promise empowerment through self-improvement and control over one’s eating habits and weight — ideals that resonate with but limit women's autonomy by keeping them focused on unattainable body standards, diverting time, money, and energy away from pursuits that could foster true empowerment. This self-imposed societal pressure creates a cycle of control that aligns with patriarchal capitalism, leaving few avenues for women to escape unless systemic changes are made in how beauty and success are marketed.9


However, socio-cultural factors cannot be viewed independent of  the individual psychological and genetic predispositions that heighten the risk of AN development. Research indicates that genetic influences account for over 40% of the variance in thin-ideal internalization.4 This genetic inclination combined with persistent socio-cultural messaging creates a fertile breeding ground for anorexia to thrive. While society may normalize thinness as beauty, not everyone will internalize this standard to the same pathological extent, illustrating an interesting battle between nature and nurture in the development of eating disorders. The differences in how individuals internalize beauty standards highlight the influence of diverse socio-cultural environments. In recent years, researchers have explored programs aimed at attempts to mitigate the development of AN.


A 2022 study conducted in the Netherlands found that positive body exposure, administered with the Positive Body Experience protocol, leads to “significant positive changes in attitudinal body image, eating pathology and depressive symptoms in female participants with eating disorders”, including anorexia nervosa “in a clinical setting”.10 However, what happens when the patients go back to their pre-clinical lives? Will the eating disorder return given the exposure to the same environments, social pressures, and media? Ultimately, resolving the pervasive issue of anorexia nervosa requires a holistic approach, addressing not only the individual psychological predispositions and AN patient’s environments but also the societal structures that engender these disorders. 


The cost of thinness—embodied in the experiences of those struggling with anorexia nervosa—reveals a mixture of socio-cultural forces and individual genetic vulnerabilities. Acknowledging the complexity of these influences is an important step towards creating a more empathetic, informed, and equitable society where individuals are valued for their intrinsic worth rather than their adherence to unrealistic and harmful body ideals. The road to recovery and prevention is not short, nor is it without its challenges. Fundamental societal change necessitates systemic solutions that go beyond individual therapy but rather incorporate economic, political, and educational reform, reshaping the way beauty is perceived in our cultures. The ethical implications are clear. Healthcare providers must address both the biological and sociocultural dimensions of AN, while society at large must recognize its role in contributing to environmental conditions that can activate genetic vulnerabilities. Only by confronting the deeply ingrained socio-cultural forces and challenging the lucrative industries that benefit from persistent body dissatisfaction can we hope to alleviate the suffering of those grappling with AN and prevent future generations from falling into these unhealthy norms.


Reviewed by Anna Chen

Graphic by Eugene Cho


References

  1. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav. 2008;94(1):121-135. doi:10.1016/j.physbeh.2007.11.037

  2. Uchôa FNM, Uchôa NM, Daniele TM da C, et al. Influence of the Mass Media and Body Dissatisfaction on the Risk in Adolescents of Developing Eating Disorders. Int J Environ Res Public Health. 2019;16(9):1508. doi:10.3390/ijerph16091508

  3. Auger N, Potter BJ, Ukah UV, et al. Anorexia nervosa and the long‐term risk of mortality in women. World Psychiatry. 2021;20(3):448. doi:10.1002/wps.20904

  4. Suisman JL, O’Connor SM, Sperry S, et al. Genetic and environmental influences on thin-ideal internalization. Int J Eat Disord. 2012;45(8):942-948. doi:10.1002/eat.22056

  5. Garner DavidM, Garfinkel PaulE. SOCIOCULTURAL FACTORS IN ANOREXIA NERVOSA. The Lancet. 1978;312(8091):674. doi:10.1016/S0140-6736(78)92776-9

  6. Allison S, Warin M, Bastiampillai T. Anorexia nervosa and social contagion: Clinical implications. Aust N Z J Psychiatry. 2014;48(2):116-120. doi:10.1177/0004867413502092

  7. Balakireva E, Zvereva N, Voronova S. Personal and clinical traits in adolescents, diagnosed with «anorexia nervosa». Eur Psychiatry. 2021;64(Suppl 1):S356. doi:10.1192/j.eurpsy.2021.953

  8. Willemsen EMC, Hoek HW. Sociocultural factors in the development of anorexia nervosa in a black woman. Int J Eat Disord. 2006;39(4):353-355. doi:10.1002/eat.20234

  9. Hesse-Biber S, Leavy P, Quinn CE, Zoino J. The mass marketing of disordered eating and Eating Disorders: The social psychology of women, thinness and culture. Womens Stud Int Forum. 2006;29(2):208-224. doi:10.1016/j.wsif.2006.03.007

  10. Rekkers ME, Aardenburg L, Scheffers M, Elburg AA van, Busschbach JT van. Shifting the Focus: A Pilot Study on the Effects of Positive Body Exposure on Body Satisfaction, Body Attitude, Eating Pathology and Depressive Symptoms in Female Patients with Eating Disorders. Int J Environ Res Public Health. 2022;19(18):11794. doi:10.3390/ijerph191811794

34 views0 comments


1:12. 0:43. 0:21. Each morning, countless Americans open their New York Times app, fingers hovering over the Mini Crossword, ready to shave off mere fractions of a second from their personal best time — a daily ritual of racing against the clock, pursuing an elusive new record. Down to 0:19. Then 0:18. The thrill of watching the clock tick lower and lower.

 

Our obsession with time isn’t limited to daily puzzles; it extends to the ultimate race: the quest for a longer life. This pursuit is anything but new — humans have been trying to outmaneuver death since we first became aware of our own mortality. From ancient Egyptian hieroglyphs to Chinese alchemical texts, from Plato's musings to Aristotle's contemplations, the dream of extending life has echoed through millennia of human civilization. However, what took centuries of philosophical pondering to even conceptualize has now quickly become a reality through scientific advancement. In short, modern medicine has transformed the abstract theories of Plato and Aristotle into concrete gains. At the beginning of the 19th century, no country's life expectancy exceeded 40 years, but today, the global average life expectancy is estimated to be 72.6 years [3]. Although life expectancy has increased across all ages, most of our dramatic gains in average lifespan have come from technological and medical breakthroughs focused on preventing early deaths — keeping infants alive, curing infectious diseases, and making childbirth safer.

 

Consequently, modern medicine has been so successful in curbing death rates among the young that we've nearly exhausted all possible improvements in early-life mortality. Now, researchers must shift their focus to a new frontier: preventing deaths in old age itself. Unlike preventing early mortality, extending life in old age means confronting bodies that have accumulated decades of biological wear and tear, where cellular damage, chronic inflammation, and deteriorating systems create a maelstrom of mortality risk. In other words, each additional year of life expectancy has become increasingly harder to achieve.

 

This challenge has led scientists down an unexpected path as researchers have begun to focus on tackling old age from its roots: can we slow aging itself? The answer may lie in an unlikely source. Rapamycin, first discovered in the soil of Easter Island, isn't a mythical fountain of youth —but its effects may have the potential to change how we experience aging itself.

 

Historically, Rapamycin has been used as an oral immunosuppressant for organ transplant patients. Recent research has uncovered, however, that at low doses, rapamycin appears to reduce inflammation by inhibiting the mTOR signaling pathway, which serves as a critical regulator of aging and the body's lifespan [1]. Inspired by this discovery, scientists such as Dr. Matt Kaeberlein have started testing in animal models, with results indicating that rapamycin usage in mice can result in up to a 30% increase in lifespan [2]. Further research has proved even more successful, as shown in a trial where a one-time 3-month dosage of rapamycin in mice resulted in longer life and substantial improvements in murine heart function [2]. Due to the extensive genetic similarities between mice and humans, scientists have started to hypothesize that rapamycin may have similarly beneficial effects on human life spans.

 

Despite promising results in animal models, significant hurdles remain before rapamycin can be considered a viable option for improving human longevity. The long-term effects in humans are still unknown, and an optimal dosage for anti-aging purposes has yet to be established. Complicating matters further, the FDA doesn't currently recognize aging as a disease, which means that 1) drugs targeting aging specifically aren’t eligible for approval as treatments, and 2) clinical trials using rapamycin are plagued by ill-fitted regulatory constraints. Thus, leading researchers on aging and rapamycin, including Dr. Matt Kaeberlein and Dr. Eric Verdin, publicly advise against using rapamycin for life extension. The twist? They are taking it themselves, prescribed off-label [4]. 

 

The actions of leading longevity researchers speak louder than their words. Dr. Kaeberlein and Dr. Verdin's actions serve antithetical to their public advice. But why? For them and many others, they don't have enough years left in their lives to wait for conclusive results from long-term studies; it's now or never. So, while unapproved, is it safe to bet on rapamycin extending your life without knowing its long-term impacts?

 

The answer varies for each individual, but regardless of personal choice, rapamycin represents a concerning shift in our approach to longevity — the pursuit of potentially harmful quick fixes over proven routines. While exercise, nutrition, and lifestyle modifications require consistent effort, they build a foundation for comprehensive health that extends beyond mere lifespan. Rapamycin, in contrast, offers a seductive shortcut that bypasses these holistic benefits. By reducing the complex journey of healthy aging to a pill, we not only risk oversimplifying the multifaceted factors that contribute to longevity but also ignore the importance of lifestyle, environment, and social determinants of health in favor of quick pharmacological fixes.

 

However, the strongest argument against rapamycin’s usage lies in its potential to deepen America's already severe health disparities. Off-label prescriptions and high costs mean that even if rapamycin proves effective for human longevity, its benefits will flow primarily to the wealthy. This accessibility issue creates an unprecedented form of inequality where money doesn’t just buy better healthcare, but also more years of life itself. In an increasingly costly healthcare environment, the wealthy already enjoy longer lives due to better access to healthcare, nutrition, and healthy lifestyles. Adding rapamycin to this equation would only widen the existing life expectancy gap, fostering a society where longevity becomes a luxury good rather than a human right.

 

Crucially, the most urgent step isn't deciding whether to take rapamycin; rather, it is reconsidering how we view aging itself. Our current regulatory framework, which doesn't recognize aging as a disease, creates a pharmaceutical catch-22: we can't properly study anti-aging treatments because aging isn't classified as a treatable condition, yet we hesitate to classify it as such because we lack proven treatments. Breaking this cycle requires a fundamental shift in how we conceptualize and regulate aging intervention research. Only by acknowledging aging as a medical condition—rather than as an inevitable decline—can we create the regulatory framework needed to properly study, develop, and equitably distribute treatments like rapamycin.

 

Until then, we're left with an uncomfortable reality: a promising compound that sits in regulatory limbo, prescribed off-label by those who can afford it, while the broader implications of its use remain underexplored. Ultimately, the debate around rapamycin isn't just about a potential life-extending drug—it's a mirror reflecting our society's complex relationship with aging, inequality, and the lengths we'll go to add a few more numbers to our personal timers.


Graphic by Monica Rashkov

Reviewed by Nick Hoffmann


References

  1. Abuery, A. (2024, July 1). Could a decades-old transplant drug unlock the secret to longer life? NPR. https://www.npr.org/sections/shots-health-news/2024/07/01/nx-s1-5008777/rapamycin-aging-disease-drug-humans-research

  2. Kaeberlein, M. (2024, January 15). Rapamycin: The most promising life extension drug [Video]. YouTube. https://www.youtube.com/watch?v=DcxgEwQKx8Q

  3. Roser, M., Ortiz-Ospina, E., & Ritchie, H. (2024). Life Expectancy. Our World in Data. https://ourworldindata.org/life-expectancy-globally

  4. Whalen, J. (2024, March 15). A transplant drug shows promise for extending life. Should you take it? The Washington Post. https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/



If you’re lactose intolerant, then you know: one scoop of ice cream is all it takes to

experience a gut-wrenching sensation. But what if lactose intolerance wasn’t solely about dairy?

New research suggests that your gut bacteria might be playing a leading role in those post-dairy

blues (Brandao Gois et al., 2020).


Let’s start with a quick refresher: lactose intolerance is usually the result of missing

lactase, the enzyme that digests lactose, the sugar in milk. Without lactase, lactose just stays in

your gut, leading to bloating, gas, and discomfort (Misselwitz et al., 2019). However, scientists

are finding that the gut microbiome, the community of trillions of bacteria in your digestive tract,

might be more involved than previously thought. One genus in particular, Bifidobacterium,

seems to be a prime suspect (Brandao Gois et al., 2020).


Bifidobacterium and other bacteria in the gut are capable of fermenting lactose. You

might think that’d help, but their “help” creates gas and byproducts that can sometimes make

lactose intolerant symptoms even worse (Misselwitz et al., 2019). In other words,

Bifidobacterium is basically acting like that overly enthusiastic friend at a karaoke party –

well-meaning, but a little too intense.


A study from the Lifelines-DEEP Dutch population cohort dove into this theory by

analyzing 959 participants. They found that people with the genetic LI variant (a particular gene

combo called G/G on SNP rs4988235) had higher Bifidobacterium populations in their gut.

Additionally, the more Bifidobacterium, the higher the frequency of GI complaints – specifically

abdominal pain, discomfort, and bloating (Brandao Gois et al., 2020). So, instead of simply

digesting lactose, these bacteria are throwing a party in your stomach (Leon, S. D., 2021).

A second study noted that Bifidobacterium actually correlates positively with dairy intake

in people with lactose intolerance but not in those without it (De Vrese et al., 2001). In other

words, the real problems seem to start when dairy enters the picture, activating these

lactose-loving bacteria, and triggering all those uncomfortable symptoms.


So what’s the takeaway? Avoiding dairy might still be your safest bet for now, but the

future might hold other options. Imagine, rather than going dairy-free, managing

Bifidobacterium levels in your gut could allow you to indulge without regretting it later.

Scientists are actively exploring gut-modifying treatments – from probiotics to dietary tweaks –

which could one day give lactose-intolerant folks a pathway to enjoy dairy without a hitch. Until

then, though, you might not want that extra scoop.


Reviewed By: Aman Meredia

Designed By: Ashley Gutierrez-Torres


References

1. Brandao Gois, M. F., Sinha, T., Spreckels, J. E., Vila, A. V., Bolte, L. A., Weersma, R. K.,

Wijmenga, C., Fu, J., Zhernakova, A., & Kurilshikov, A. (2020). Role of the gut

microbiome in mediating lactose intolerance symptoms. Gut.

2. De Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue, C., & Schrezenmeir, J.

(2001). Probiotics – compensation for lactase insufficiency. The American Journal of

Clinical Nutrition.

3. Foster, P. (2019, April 11). Can changing the microbiome reverse lactose intolerance?.

Department of Biology.

https://biology.indiana.edu/news-events/news/2019/foster-lactose-intolerance.html

4. Leon, S. D. (2021, June 18). Lactose intolerance: Bacteria that causes it and how to treat

it. Floré by Sun Genomics. https://flore.com/blogs/learn/lactose-intolerance-bacteria-that-causes-it-and-how-to-treat-it?srsltid=AfmBOoq-gZlTLRZ2ksgmFhYTKeTTUQ3FNjeSxvEiGs5-eFgfyrPH12o9

5. Misselwitz, B., Butter, M., Verbeke, K., Fox, M. R., & Vanner, S. J. (2019). Update on

lactose malabsorption and intolerance: Pathogenesis, diagnosis, and clinical management.

Gut and Liver.

9 views0 comments

DMEJ

   Duke Medical Ethics Journal   

bottom of page